
Take Solutions Ltd — Investor Relations & Filings
Take Solutions Ltd provides specialized domain-led technology and services, primarily focusing on the Life Sciences sector. Through its key brand, Navitas Life Sciences, the company delivers end-to-end solutions across clinical research, regulatory affairs, and pharmacovigilance. Its service offerings include clinical data management, medical writing, and trial monitoring, leveraging proprietary platforms to enhance operational efficiency. The organization supports pharmaceutical, biotechnology, and medical device companies in managing complex regulatory requirements and streamlining the drug development process. By combining deep functional expertise with digital transformation capabilities, Take Solutions facilitates data-driven decision-making and ensures compliance with global safety standards. Its portfolio encompasses strategic consulting and technology-enabled services designed to optimize clinical trial outcomes and accelerate time-to-market for new therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Outcome of Board Meeting | 2026-05-13 | English | |
| Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | |
| Press Release | 2026-04-17 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | |
| Press Release | 2026-04-06 | English | |
| Change in Auditors | 2026-03-26 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45564189 | Outcome of Board Meeting | 2026-05-13 | English | ||
| 45552703 | Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | ||
| 42209881 | Press Release | 2026-04-17 | English | ||
| 42189767 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | ||
| 42213664 | Press Release | 2026-04-06 | English | ||
| 42163155 | Change in Auditors | 2026-03-26 | English | ||
| 42163370 | Outcome of Board Meeting | 2026-03-26 | English | ||
| 42178686 | Resignation | 2026-03-25 | English | ||
| 42179973 | Trading Window | 2026-03-25 | English | ||
| 42190231 | Press Release | 2026-03-25 | English | ||
| 42170276 | General Updates | 2026-03-11 | English | ||
| 42187987 | Shareholders meeting | 2026-03-07 | English | ||
| 42188107 | Shareholders meeting | 2026-03-07 | English | ||
| 42193993 | Press Release | 2026-02-21 | English | ||
| 42175686 | Record Date | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Syngene International Limited
Integrated scientific services for discovery, development, …
|
SYNGENE | IN | Professional, scientific and te… |
|
SYNTARA LIMITED
Clinical-stage developer of small molecule drugs for inflam…
|
SNT | AU | Professional, scientific and te… |
|
SyntekaBio,Inc.
An AI-driven drug discovery company using supercomputing to…
|
226330 | KR | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
Take Solutions Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60381/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60381 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60381 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60381 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60381}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Take Solutions Ltd (id: 60381)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.